Compositions for inhibiting NADPH oxidase activity
US8709434B2 · kind B2 · utility
0Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2007 |
| Grant date | Apr 29, 2014 |
| Priority date | — |
| Expiry date | Aug 15, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Phycobilins are disclosed to have prodrug activity as inhibitors of NADPH oxidase activity and are disclosed to be useful in the prophylaxis and/or treatment of medical conditions associated with or linked to an NADPH oxidase activity. Compositions containing phycobilins are described which facilitate the administration of phycobilins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.